Do you want to read an article? Please log in or register.
Omalizumab versus Mepolizumab as add-on therapy in asthma patients not well controlled on at least an inhaled corticosteroid: A network meta-analysis
Asthma
Related content
Asthma
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
Lancet Respir Med.
Chupp GL, Bradford ES, Albers FC, Bratton DJ, Wang-Jairaj J, Nelsen LM, Trevor JL, Magnan A, Ten Brinke A
doi: 10.1016/
RECOMMENDED
COPD
Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis
Cochrane Database Syst Rev.
Oba Y, Keeney E, Ghatehorde N, Dias S
doi: 10.1002/14651858.
COMMENTED
Asthma
Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β2-agonists for adults with asthma
Respir Med.
Buhl R, FitzGerald JM, Busse WW
doi: 10.1016/j.rmed.2018.08.014.
RECOMMENDED
Asthma
Tiotropium Respimat® add-on therapy to inhaled corticosteroids in patients with symptomatic asthma improves clinical outcomes regardless of baseline characteristics
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med.
Casale TB, Aalbers R, Bleecker ER, Meltzer EO, Zaremba-Pechmann L, de la Hoz A, Kerstjens HAM
doi: 10.1016/j.rmed.2019.09.014.
RECOMMENDED
Asthma
Impact of patient satisfaction with his or her inhaler on adherence and asthma control
Allergy Asthma Proc.
Plaza V, Giner J, Calle M, Rytilä P, Campo C, Ribó P, Valero A
doi: 10.2500/aap.2018.39.4183.
COMMENTED
Asthma
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
Lancet Respir Med.
Heaney LG, Busby J, Hanratty CE, Djukanovic R, Woodcock A, Walker SM, Hardman TC, Arron JR, Choy DF, Bradding P, Brightling CE, Chaudhuri R, Cowan DC, Mansur AH, Fowler SJ, Niven RM, Howarth PH, Lordan JL, Menzies-Gow A, Harrison TW, Robinson DS, Holweg CTJ, Matthews JG, Pavord ID, investigators for the MRC Refractory Asthma Stratification Programme.
doi: 10.1016/S2213-2600(20)30397-0.
Asthma
Efficacy and safety of benralizumab in patients with eosinophilic asthma: a meta-analysis of randomized placebo-controlled trials
Front Med.
Liu T, Wang F, Wang G, Mao H
doi: 10.1007/s11684-017-0565-0.
Asthma
The pediatric asthma yardstick: practical recommendations for a sustained step-up in asthma therapy for children with inadequately controlled asthma
Ann Allergy Asthma Immunol.
Chipps BE, Bacharier LB, Farrar JR, Jackson DJ, Murphy KR, Phipatanakul W, Szefler SJ, Teague WG, Zeiger RS
doi: 10.1016/j.anai.2018.04.002.
RECOMMENDED
Asthma
SMART and as-needed therapies in mild to severe asthma: a network meta-analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J.
Rogliani P, Ritondo BL, Ora J, Cazzola M, Calzetta L
doi: 10.1183/13993003.00625-2020.